Bio-Techne (TECH) Misses Q4 EPS by 3c

Go back to Bio-Techne (TECH) Misses Q4 EPS by 3c

Bio-Techne Corp. (TECH) PT Lowered to $500 at Stifel

August 4, 2022 3:52 PM EDT

Stifel analyst Daniel Arias lowered the price target on Bio-Techne Corp. (NASDAQ: TECH) to $500.00 (from $560.00) while maintaining a Buy rating following results.

The analyst commented, "TECH's finish to fiscal 2022 was solid, and marked by 14% organic that brought FY22 to 16%. Looking to FY23, mgmt's... More